Literature DB >> 2854595

Reovirus infection in adult mice: the virus hemagglutinin determines the site of intestinal disease.

D H Rubin1, M A Eaton, A O Anderson.   

Abstract

Reovirus type 1, strain Lang, and type 3, strain Dearing, induced site-specific intestinal lesions in the adult mouse after intravenous inoculation. Reovirus type 1 caused inflammation and epithelial changes such as loss of nuclear polarity, villus blunting and crypt hyperplasia restricted to the ileum. In contrast, reovirus type 3 induced duodenitis, jejunitis, and ulcerative colitis. In the duodenum and jejunum, the epithelial cells appeared normal, but hemorrhage and inflammation in the lamina propria was present. In the colon, superficial ulceration, crypt abscesses, and intraluminal hemorrhage was observed. Segregation analysis using reassortant clones derived from reoviruses 1 and 3, suggested the viral hemagglutinin, encoded by genome segment S1, to be the major viral determinant of site specific intestinal disease following intravenous inoculation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2854595      PMCID: PMC7172823          DOI: 10.1016/0882-4010(86)90034-3

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  14 in total

1.  Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3.

Authors:  R F Ramig; R K Cross; B N Fields
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

2.  Reovirus serotype 1 intestinal infection: a novel replicative cycle with ileal disease.

Authors:  D H Rubin; M J Kornstein; A O Anderson
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

Review 3.  The evolutionary origins of hormones, neurotransmitters, and other extracellular chemical messengers: implications for mammalian biology.

Authors:  J Roth; D LeRoith; J Shiloach; J L Rosenzweig; M A Lesniak; J Havrankova
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

4.  Reovirus inhibition of cellular RNA and protein synthesis: role of the S4 gene.

Authors:  A H Sharpe; B N Fields
Journal:  Virology       Date:  1982-10-30       Impact factor: 3.616

5.  Genetic and molecular mechanisms of viral pathogenesis: implications for prevention and treatment.

Authors:  B N Fields; M I Greene
Journal:  Nature       Date:  1982-11-04       Impact factor: 49.962

Review 6.  Rotaviruses: a review.

Authors:  M K Estes; E L Palmer; J F Obijeski
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

7.  Immunologic tolerance after oral administration of reovirus: requirement for two viral gene products for tolerance induction.

Authors:  D Rubin; H L Weiner; B N Fields; M I Greene
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

8.  Multiplicity reactivation of reovirus particles after exposure to ultraviolet light.

Authors:  M E McClain; R S Spendlove
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

9.  T lymphocyte immunity to reovirus: cellular requirements for generation and role in clearance of primary infections.

Authors:  N L Letvin; R S Kauffman; R Finberg
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

10.  Molecular basis of reovirus virulence. Role of the M2 gene.

Authors:  D H Rubin; B N Fields
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Mucosal T cell response to reovirus.

Authors:  D Chen; D H Rubin
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Binding of type 3 reovirus by a domain of the sigma 1 protein important for hemagglutination leads to infection of murine erythroleukemia cells.

Authors:  D H Rubin; J D Wetzel; W V Williams; J A Cohen; C Dworkin; T S Dermody
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 3.  Mechanisms of reovirus bloodstream dissemination.

Authors:  Karl W Boehme; Caroline M Lai; Terence S Dermody
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

4.  Reovirus type 1 is secreted into the bile.

Authors:  D H Rubin; M A Eaton; T Costello
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

5.  Synergism between hepatic injuries and a nonhepatotropic reovirus in mice. Enhanced hepatic infection and death.

Authors:  D A Piccoli; C L Witzleben; C J Guico; A Morrison; D H Rubin
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus.

Authors:  L Yuan; S Y Kang; L A Ward; T L To; L J Saif
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Transport of infectious reovirus into bile: class II major histocompatibility antigen-bearing cells determine reovirus transport.

Authors:  D H Rubin; T Costello; C L Witzleben; M I Greene
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

8.  Selective reovirus infection of murine hepatocarcinoma cells during cell division. A model of viral liver infection.

Authors:  J Taterka; M Sutcliffe; D H Rubin
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  Sialoglycovirology of Lectins: Sialyl Glycan Binding of Enveloped and Non-enveloped Viruses.

Authors:  Nongluk Sriwilaijaroen; Yasuo Suzuki
Journal:  Methods Mol Biol       Date:  2020

10.  Reovirus-induced liver disease in severe combined immunodeficient (SCID) mice. A model for the study of viral infection, pathogenesis, and clearance.

Authors:  A George; S I Kost; C L Witzleben; J J Cebra; D H Rubin
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.